Unrivaled expertise in pharmaceutical contract research

A key advantage of partnering with Solvias for CMC analytical services is the expertise and experience of our team. Our experts have the know-how, creativity, and tenacity to solve the analytical challenges associated with cutting-edge drug development.


The Solvias team’s expertise in genomic characterization has helped us establish the assays needed for each of our CRISPR genome-edited CAR-T cell therapies. (Click for full testimonial.)

Scott Gradia, PhD Vice President of Platform Research, Caribou Biosciences

The scientific delivery of this quality work from the Solvias team exceeded industry standards. The team are masters of their craft.

Doug Daniels Sr. Director, QC, Veloxis Pharmaceuticals

The drug delivery and physical characterization team provided outstanding support to fine tune analytical methods, perform product specific characterization studies and to complete in vitro BE studies required for product filing at the US FDA.

Dr. Clarissa Gobetti Chief Scientific Officer, Phargentis
decorative roadmap graphic

Contact us for a complimentary consultation